CK Clinical will be attending the 6th Pharmacovigilance 2014 event which will take place this year on the 4th & 5th of March 2014 at the Thistle Marble Arch Hotel in London.
The theme of the event is “Ensuring safer drugs to market by analysing the latest developments in pharmacovigilance, drug safety and risk management”
CK Clinical are delighted to attend this event as the conference will bring together top pharmaceutical, biotechnology and regulatory representatives to address the key issues that are facing the industry. The organisers promise that the entire program will cover the detection, analysis and prevention of adverse drug reactions.
Here are just a few of the key speakers named to present at the conference:
- Joan Francesc Aregall Picamal, Pharmacovigilance Country Head, Bayer
- William Gregory, Director, Safety and Risk Management, Pfizer
- Christina Strom Moller, Vice President – Patient Safety Late Development & Marketed Products, AstraZeneca
- Arlene Gallagher, Statistician, Epidemiologist Clinical Practice Research Datalink, MHRA
CK Clinical Recruitment Consultants Hendre Moolman, Jim Gleeson and Melanie Miles will be attending the conference, if you would like to meet up to chat to any of these then please contact them on the below details:
Hendre Moolman: firstname.lastname@example.org
Jim Gleeson: email@example.com